Knowledge popularization

Hematology analyzers are evolving at an unprecedented pace—from impedance-only counters to AI-driven, all-in-one diagnostic platforms that reshape how laboratories operate worldwide. The global hematology analyzer market, valued at approximately 4.33 billion USD in 2025, is projected to reach 7.28 billion USD by 2034, expanding at a compound annual growth rate (CAGR) of 5.97% over this […]

The global hematology analyzer market represents one of the most critical segments in laboratory diagnostics, with complete blood count (CBC) testing remaining an indispensable tool in modern healthcare. As facilities worldwide seek to balance diagnostic accuracy with operational efficiency and cost containment, the choice of hematology analyzer manufacturer becomes increasingly important. Ozelle Diagnostics has emerged

Complete blood count (CBC) testing is one of the most fundamental diagnostic procedures in modern healthcare, providing critical insights into patient health through rapid, reliable blood analysis. Whether you’re working in a busy clinical laboratory, a point-of-care facility, or a veterinary diagnostic center, understanding How to Use a CBC Machine is essential for delivering accurate

Healthcare facilities across the globe face a critical decision when selecting point-of-care (POC) blood analyzers. The market offers numerous options, each with distinct capabilities, pricing models, and operational requirements. This procurement choice directly impacts laboratory efficiency, patient outcomes, and overall healthcare costs, yet many decision-makers struggle to navigate the technical complexities and feature differentiation between

Introduction & Executive Summary Selecting a veterinary hematology analyzer ranks among the most important equipment decisions a practice can make. The right analyzer accelerates diagnostic efficiency, improves patient outcomes, and strengthens your clinical decision-making. Yet with dozens of models available, equipment costs ranging from $1,700 to $10,000+, and consumable expenses consuming 60-70% of total operating

Why Selecting the Right CBC Hematology Analyzer Matters The Complete Blood Count (CBC) is one of the most frequently ordered diagnostic tests in healthcare. Selecting the appropriate hematology analyzer represents a critical investment decision that extends far beyond the initial purchase price. The right equipment directly impacts diagnostic accuracy, clinical outcomes, and operational efficiency while

Point-of-care testing (POCT) has emerged as one of the most transformative trends in primary healthcare delivery. In community health centers, private clinics, pharmacies, urgent care facilities, and general practitioner offices, immediate diagnostic capability means faster patient outcomes, better treatment decisions, and enhanced care quality. At the heart of this revolution is the compact hematology analyzer—specifically

Selecting a blood analyzer is a critical investment decision for healthcare facilities. Laboratory managers, clinic directors, and procurement specialists must evaluate not just product models, but the fundamental analytical approach: traditional Complete Blood Count (CBC) methods that provide quantitative data alone, or AI-powered Complete Blood Morphology (CBM) systems that integrate visual cell analysis for superior

Selecting a blood analyzer is a critical investment decision for healthcare facilities. Laboratory managers, clinic directors, and procurement specialists must evaluate not just product models, but the fundamental analytical approach: traditional Complete Blood Count (CBC) methods that provide quantitative data alone, or AI-powered Complete Blood Morphology (CBM) systems that integrate visual cell analysis for superior

The Starting Point — From Traditional CBC Analyzer to Intelligent Blood Diagnostics For decades, the Complete Blood Count (CBC) has been the cornerstone of Blood diagnostics, delivering essential quantitative data — red blood cells, white blood cells, hemoglobin, platelets — but telling only part of the story. Clinical decisions often depend on what lies beyond